Delivery Order SPE2DE24DA010-SPE2D626F07TR
- Not listed
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $28,350 on January 7, 2026, by the Defense Logistics Agency's Medical Supply Chain. This fixed-price contract with economic price adjustment is scheduled for completion by January 20, 2026, and will be performed in Santa Clara, California. The delivery order carries no set-aside designation and was awarded through full and open competition, reflecting Abbott's established competitive...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $24,350 by the Defense Logistics Agency's Medical Supply Chain on December 2, 2025, with an ultimate completion date of December 5, 2025. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries no set-aside designation, reflecting Abbott's competitive positioning among qualified federal contractors. Performance will take place in...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a delivery order award valued at $24,350 from the Defense Logistics Agency Medical Supply Chain on December 18, 2025, with an ultimate completion date of December 23, 2025. The contract employs a fixed-price structure with economic price adjustment terms and carries no set-aside designation, reflecting full and open competition. Performance will occur at Abbott Vascular's Santa Clara, California location. This delivery...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $24,350 on November 25, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This fixed-price delivery order with economic price adjustment is scheduled for completion by December 2, 2025, and will be performed in Santa Clara, California. The award utilized full and open competition with no set-aside designation, consistent with Abbott Vascular's established competitive...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $11,750 on November 4, 2025, by the Defense Logistics Agency's Medical Supply Chain for cardiovascular medical devices and related technologies. The contract, which is not set-aside and operates under a fixed-price structure with economic price adjustment provisions, is scheduled for completion by November 7, 2025, with performance taking place in Santa Clara, California. This delivery...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $24,350 by the Defense Logistics Agency's Medical Supply Chain on November 14, 2025, with an ultimate completion date of November 19, 2025. The delivery order, which carries no set-aside designation, will be performed in Santa Clara, California. This award represents a task order issued under Abbott's existing $117.1 million Indefinite Delivery Contract with the Defense...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $14,850 on November 14, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by November 19, 2025, and will be performed in Santa Clara, California. The award represents a child contract under Abbott Laboratories Inc.'s broader federal contracting portfolio and was made...
- Abbott Laboratories Inc.'s Abbott Vascular Inc. division received a $28,350 fixed-price delivery order (4570509248) from the Defense Logistics Agency's Medical Supply Chain on January 7, 2026, with an ultimate completion date of January 20, 2026. This delivery order was awarded without a set-aside designation through full and open competition and will be performed in Santa Clara, California. The award represents a task order under Abbott's existing $117.1 million Indefinite Delivery Contract...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a delivery order award valued at $5,695.00 from the Defense Logistics Agency's Medical Supply Chain on December 10, 2025, with an ultimate completion date of December 15, 2025. The contract utilizes a fixed-price structure with economic price adjustment pricing and was awarded without a set-aside designation through full and open competition. Performance will take place in Santa Clara, California, positioning the award...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $37,164.80 by the Medical Supply Chain division of the Department of Defense on June 18, 2025, with a completion date of June 24, 2025. The award is designated as a fixed-price contract with economic price adjustment and was issued without a set-aside, indicating full and open competition. Performance will be executed at Abbott's facility in Santa Clara, California. This delivery order...
- SPE2DE24DA010Indefinite Delivery Contract
- SPE2DE24DA010-SPE2D626F07TRDelivery Order
Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a delivery order award valued at $28,350 from the Defense Logistics Agency's Medical Supply Chain on January 7, 2026, with an ultimate completion date of January 20, 2026. The contract utilizes a fixed-price structure with economic price adjustment provisions and carries no set-aside designation, reflecting full and open competition. Performance will take place in Santa Clara, California, where Abbott maintains significant manufacturing and distribution capabilities for cardiovascular medical technologies. This delivery order represents a task order execution under Abbott's established relationship with the Defense Logistics Agency, which maintains a major indefinite delivery contract valued at $117.1 million for comprehensive cardiovascular procedural packages covering devices, instrumentation, accessories, and related medical technologies. Abbott Vascular has demonstrated consistent success in federal cardiovascular procurement through its portfolio of advanced medical devices including stents, pacemakers, heart valves, implantable cardiac monitors, left ventricular assist devices, and transcatheter valve repair systems. The company serves as a critical supplier to both the Department of Defense and Department of Veterans Affairs healthcare networks across multiple Veterans Integrated Service Networks, positioning it as an essential provider within the federal government's medical supply infrastructure for supporting complex cardiovascular procedures and improving military and veteran healthcare outcomes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.4k | 1/6/26 |